Blood vessels were perfused, retinas were isolated and incubated in Krebs-HEPES buffer (with 5mmol/L glucose) for 25 min at 37°C in 5% CO2. Luminescence was measured 5 min after the addition of 0.5 mmol/L lucigenin, as previously described6. Alternatively, 2’,7’-dichlorodihydrofluorescein diacetate (CFDA), was used as an indicator for ROS by flow cytometry analysis as previously described12. Anti-IL-17RC was added 2h prior to IL-17A stimulation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.